CORREVIO PHARMA Stock Price (NASDAQ:CORV)

Add to My Stocks
$4.82 $0.08 (1.69%) CORV stock closing price Aug 14, 2018 (Closing)
Prev Close* : $4.74
Market Cap:
$165.29M
Day Low: $4.62
52 Week Low: $1.29
Open: $4.99
Volume: -
Day High: $4.99
52 Week High: $5.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

CORREVIO PHARMA News - From Partners

Correvio Announces Brinavess   by PRNews on Aug 14, 2018
New Strong Sell Stocks for April 14th   by Zacks on Apr 14, 2016
New Strong Sell Stocks for April 12th   by Zacks on Apr 12, 2016
New Strong Sell Stocks for March 21st   by Zacks on Mar 21, 2016

CORV Stockcharts

View CORV PE ratio, PS ratio stocks charts and compare with peers.
CORV Chart
Note: Compare CORREVIO PHARMA stock price history with the index and industry peers.

CORREVIO PHARMA Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
6.6
PB ratio (
price to book ratio
)
7.91

CORREVIO PHARMA Returns

ROE
(return on equity)
-151%

CORREVIO PHARMA Financial Ratios

Asset Turnover
0.42
Receivables Turnover
4.09
Debt to Equity
4.31
Dividend Yield
0%

CORV Industry Peers

Company Price Change (%)
Melinta Therapt (MLNT)4.70.2 (4.08%)
Neous Therapeutics (NEOS)5.950.15 (2.46%)
Nature's Sunshine Products (NATR)9.20.25 (2.65%)
Merus Labs International (MSLI)1.30 (0%)
Johnson & Johnson (JNJ)129.50.72 (0.55%)
Arca Biopharma (ABIO)0.620.01 (1.64%)
Eli Lilly (LLY)102.440 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)5.210.34 (6.98%)
TherapeuticsMD (TXMD)5.490.33 (6.4%)
ArQule (ARQL)6.020.34 (5.99%)
Endo International (ENDP)16.10.91 (5.99%)
MADRIGAL PHARMA (MDGL)236.8810.47 (4.62%)
Infinity Pharma (INFI)2.070.09 (4.55%)
PTC Therapeutics (PTCT)44.891.75 (4.06%)
Top gainers from Medical-Drugs industry
* As of Aug 15, 2018
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.291.38 (10.89%)
BioSpecifics Technologies (BSTC)49.963.65 (6.81%)
Galmed Pharma (GLMD)11.160.65 (5.5%)
Portola Pharma (PTLA)26.221.47 (5.31%)
Flexion Therapeutics (FLXN)22.831.13 (4.72%)
ACER THERAPEUTS (ACER)27.771.23 (4.24%)
MELINTA THERAPT (MLNT)4.70.2 (4.08%)
Top losers from Medical-Drugs industry
* As of Aug 15, 2018

CORREVIO PHARMA Stock News - Partner Headlines

CORREVIO PHARMA Financial Statements

income statement20172016201520142013
Net Sales or Revenues24M25.25M20.91M30.04M4.51M
Net Income-29.81M-19.61M-24.46M-18.22M4.77M
Total Operating Expense40.2M33.49M36.39M35.96M16.44M
View CORREVIO PHARMA income statement
balance sheet20172016201520142013
Total Assets66.81M67.05M48.63M50.11M47.33M
Total Liabilities50.62M33.03M28.69M32.97M24.68M
Shareholders Equity16.19M34.02M19.93M17.13M22.64M
View CORREVIO PHARMA balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.79M-1.62M1.26M--1.81M
Net Cash from (used by) Operating Activities-24.13M-15.98M-16.3M-18.52M-16.76M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.01M-0.13M-0.52M-0.03M
View CORREVIO PHARMA cash flow statement

CORREVIO PHARMA Stock Message Board